期刊文献+

75岁以上高龄冠心病患者经桡动脉途径介入治疗的可行性及安全性

下载PDF
导出
摘要 目的探讨75岁以上高龄冠心病患者经桡动脉途径介入治疗的可行性及安全性。方法 120例冠心病患者均为本院2014年10月至2016年10月期间收治,按照年龄不同分为两组,每组60例,所有患者均行经桡动脉途径介入治疗。统计两组患者手术成功率,并就两组患者住院期间并发症及不良事件的发生情况进行比较。结果观察组患者手术成功55例、对照组成功57例,两组比较无明显差异(P>0.05)。住院期间,观察组总计发生并发症6例,发生率10%,不良事件3例(5%);对照组总计发生并发症5例,发生率8.33%,不良事件2例(3.33%),两组比较无明显差异(P>0.05)。结论针对75岁以上高龄冠心病患者来说,行经桡动脉途径介入治疗是可行的,不但能大大提高患者的存活率,且安全性较高,值得推广。
作者 王魁风
出处 《内蒙古医学杂志》 2017年第2期203-204,共2页 Inner Mongolia Medical Journal
  • 相关文献

参考文献5

二级参考文献38

  • 1陈蕾,乔薇,焦媛,钱端,郑霄云,张小平.超高龄冠心病患者介入治疗的临床及并发症分析[J].中华临床医师杂志(电子版),2011,5(21):6440-6442. 被引量:8
  • 2吕树铮.冠心病介入治疗新进展[J].中华老年心脑血管病杂志,2007,9(3):145-148. 被引量:12
  • 3Bathelor WB,Anstom KJ,Muhlbaier LH,et al. Cotemporary outcome trends in elderly undergoing percutaneous coronary interventions: Results in 7472 octogenarians. National Cardiovascular Network Collaboration[J]. J Am Coil Cardiol,2000,36(3):723-30.
  • 4Mu OJ,Alonso JJ,Duran JM,et al. Coronary stent implantation in p tients older than 75 years of age:clinical profile and initial andlongterm (3 years) outcome[J]. Am Heart J,2002,143(4):620-6.
  • 5Kjemeneij F,Laaman GJ,Odekerken MS,et al. A randomized comparison of percutaneous transluminan coronary angioplasty by the radial,brachial and femoral approaches:The access study[J]. J Am coil Cardial, 1997,29(6): 1269-75.
  • 6Kiemenei JF,Laarman GJ. Percutaneous transradial artery approach for coronary palmaz-schatzstent implantation[J]. Am heart J,1994,128(1):167-74.
  • 7Agostoni P,Biondi-Zoccai GC,De Benedicts ML,et al. Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures: systematic overview and meta-analysis of randomized trials[J]. J Am Coil Cardiol,2004, 44(2) :349-56.
  • 8Johy SS,Amlani S,Hamon M,et al. Radial versus femoral access for coronary angiography or interventional and the impact on major bleeding and ischemic events: a systematic review and recta-analysis of randomized trials[J]. Am Heart J,2009,157(1): 132-40.
  • 9Resnic FS,Blake GJ,Ohno-Machado L,et al. Vascular closure devices and the risk of vascular complications after percutaneous coronary intervention in patients receiving glycoprotein l] h2]][a inhibitors[J]. Am J Cardiol,2001,8(5):493-6.
  • 10Aronow HD,Steinhubl SR,Brennan DM,et al. Bleeding risk associated with 1 year of dual antip latelet therapy after percutaneous coronary intervention:Insights from the Clop idogrel for the Reduction of Events During Observation(CREDO)trial[J]. Am Heart J,2009, 157(2):369-74.

共引文献93

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部